Reference number : 093-2024-2025-Q2-00012, amendment number : , agreement type : C, recipient legal name : Pharma Glycovax inc.|Pharma Glycovax inc., recipient country : CA, recipient province : QC, recipient city : Montréal, recipient postal code : H3J 1S6, program name english : The Regional Economic Growth Through Innovation Program (REGI), program name french : Le Programme De Croissance Économique Régionale Par L'Innovation (CERI), program purpose english : Commercialization and exportation, program purpose french : Commercialisation et exportation, agreement title english : 600071901, agreement title french : 600071901, agreement number : 600071901, agreement value : 250000.0, agreement start date : 2024-06-28, agreement end date : 2026-02-28, description english : Marketing strategy: The project aims to market the products of a company specialized in the development of molecules used in the manufacturing of vaccines and medical treatments., description french : Stratégie de commercialisation : le projet vise la commercialisation des produits d'une entreprise spécialisée dans le développement de molécules entrant dans la fabrication de vaccins et traitements médicaux., expected results english : -, expected results french : -, additional information english : Repayable contribution, additional information french : Contribution remboursable, owner organization : ced-dec, owner organization title : Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec